ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $99,702,000 | +31.7% | 316,204 | +46.3% | 3.99% | +45.1% |
| Q4 2021 | $75,712,000 | -31.5% | 216,204 | -41.0% | 2.75% | -36.3% |
| Q3 2021 | $110,594,000 | -43.6% | 366,204 | -43.8% | 4.32% | -41.3% |
| Q2 2021 | $196,058,000 | +130.0% | 651,204 | +110.3% | 7.35% | +129.8% |
| Q1 2021 | $85,260,000 | +363.9% | 309,599 | +395.4% | 3.20% | +342.2% |
| Q4 2020 | $18,378,000 | -58.7% | 62,491 | -63.2% | 0.72% | -70.2% |
| Q3 2020 | $44,523,000 | -49.3% | 169,600 | -56.5% | 2.42% | -55.2% |
| Q2 2020 | $87,840,000 | +2567.5% | 390,000 | +1460.0% | 5.42% | +1664.2% |
| Q1 2020 | $3,293,000 | -17.9% | 25,000 | 0.0% | 0.31% | +1.0% |
| Q4 2019 | $4,013,000 | -60.3% | 25,000 | -69.1% | 0.30% | -73.1% |
| Q1 2019 | $10,096,000 | +30.0% | 80,868 | 0.0% | 1.13% | +11.3% |
| Q4 2018 | $7,769,000 | +33.4% | 80,868 | +5.3% | 1.02% | +98.2% |
| Q3 2018 | $5,825,000 | – | 76,808 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |